A New Collaborative to Better Predict, Prevent, and Treat Type 1 Diabetes

MAI-T1D Project Launched to Map Type 1 Diabetes Progression Using Multi-modal AI

Author | Molly Dwyer-White

Type 1 Diabetes is a lifelong chronic disease affecting more than 1.7 million Americans, including over 300,000 children and adolescents. To better prevent and treat this disease, it’s important to fully understand how and why it develops. The new Multimodal AI for Type 1 Diabetes (MAI-T1D) project – funded by the National Institutes of Health – aims to use the latest advances in artificial intelligence (AI) alongside a wide range of health data to speed up discoveries to better treat and prevent T1D.  

Diagram depicting the system's components in a circular format, showcasing their relationships and roles within the system.

MAI-T1D is a collaboration between scientists from leading institutions, including the University of Michigan, UCLA, Vanderbilt University, Weill Cornell Medicine, and the University of South Florida. Together, they are building new AI models that examine a variety of information, like genetics, proteins, and changes in individual cells, to better map how T1D develops – from the signs of immune system changes through to symptoms and diagnosis. The aim is to uncover what causes the immune system to attack insulin-producing cells, understand how these cells decline, and find ways to prevent or delay T1D – even before it causes symptoms. 

To train and test these AI models, the team will use large, detailed datasets from the Human Pancreas Analysis Program (HPAP), which studies pancreas samples from healthy people and people with T1D at various stages, with a commitment to scientifically rigorous and responsible use of data. They will also use data from TEDDY (The Environmental Determinants of Diabetes in the Young) an international study that follows children who are genetically at-risk for T1D, tracking their health and environmental exposures over time.

Led by Jie Liu, Ph.D. (University of Michigan), and bringing together more than 25 scientists with experience in AI, genetics, and diabetes research, the MAI-T1D team hopes to advance our understanding of T1D. genetics, integrative multi-omics). Their ultimate goal is to make it possible to predict and prevent the disease more precisely, improving lives for those with or at risk for T1D.

Key investigators include Shuibing Chen, Ph.D. (Cornell University; single-cell and spatial multi-omics), Marcela Brissova, Ph.D. (Vanderbilt University; islet biology, HPAP leadership), Kenneth Young, Ph.D. (University of South Florida; AI and bioinformatics for TEDDY, TrialNet, RADIANT), Kai-Wei Chang, Ph.D., and Wei Wang, Ph.D. (UCLA; multimodal AI and foundation models), and Stephen Parker, Ph.D. (University of Michigan; diabetes genetics, integrative multi-omics)

References:

Centers for Disease Control and Prevention. (2021). National Diabetes Statistics Report: Data and Research Portal. U.S. Department of Health & Human Services. Retrieved from https://www.cdc.gov/diabetes/php/data-research/


 

In This Story
Jie Liu

Jie Liu, PhD

Associate Professor

Steven Parker

Stephen CJ Parker, PhD

Professor

Featured News & Stories

 Marie-Clair O'Dwyer
Department News

First national survey by U-M clinician-researchers finds nearly all family medicine residencies teach menopause care

U-M’s Department of Family Medicine and Department of Obstetrics and Gynecology, as well as the Cleveland Clinic Primary Care Institute, conducted a first-of-its kind national survey, which determined that menopause education was present among 94% of resident training programs in the U.S.
 pattern up close sequencing gene navy yellow
Health Lab

Comprehensive DNA sequencing reveals hidden drivers of cancer

Two research papers describe how long-read nanopore sequencing can detect alterations in cancer cells that might be missed by conventional sequencing.
 Med student Noah Carey, a smiling bearded man in a dark cap and T-shirt stands at a scenic overlook above lush green mountains and the ocean beneath a cloudy blue sky.
Points of Blue

Noah Carey, MD/MPH student: Connecting medicine, public health and purpose

University of Michigan medical student Noah Carey shares how mentorship and community have helped him grow as a physician, researcher and public health advocate while giving him the opportunity to pursue what matters.
 Drs. Brent Hollenbeck, Todd Morgan, and Billy Tsai
Medical School News

Regents approve Urology acting chairs, Cell and Developmental Biology interim chair

The Board of Regents on Oct. 15 approved the appointments of two acting chairs and one interim chair in the Medical School. Effective Sept. 18, Brent K. Hollenbeck, M.D. M.S., is acting chair of the Department of Urology through Feb. 28, 2027. Effective March 1, 2027, Todd M. Morgan, M.D., will assume the role of acting chair. Billy Tsai, Ph.D., is interim chair of the Department of Cell and Developmental Biology, effective Sept. 9.
 Keith E. Cook, Ph.D., M.S.
Medical School News

Keith E. Cook, PhD, MS, appointed Chair of Biomedical Engineering

The Board of Regents has approved the appointment of Keith E. Cook, Ph.D., M.S., as the William and Valerie Hall Department Chair of Biomedical Engineering, effective Jan. 1. He is returning to the University of Michigan after 13 years at Carnegie Mellon University (CMU), where he served as the David Edward Schramm Professor and head of CMU’s Department of Biomedical Engineering.
 Two older women looking at the Medicare website on a laptop screen
Health Lab

Many older adults make Medicare decisions quickly and most don’t change plans, poll finds

Sixty percent of older adults spend less than an hour choosing their Medicare coverage during Open Enrollment, a new poll finds.